日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.

食管鳞状细胞癌中转铁蛋白受体的过度表达提示预后不良和潜在治疗。

Ikenaga Naoki, Takahashi Tsuyoshi, Tanaka Koji, Serada Satoshi, Fujimoto Minoru, Momose Kota, Yamashita Kotaro, Makino Tomoki, Saito Takuro, Yamamoto Kazuyoshi, Kurokawa Yukinori, Nakajima Kiyokazu, Fujii Tomomi, Morii Eiichi, Naka Tetsuji, Eguchi Hidetoshi, Doki Yuichiro

Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells

靶向Yes相关蛋白以克服胃肠道间质瘤耐药持续细胞的伊马替尼耐药性

Yokouchi, Takashi; Takahashi, Tsuyoshi; Nishida, Toshirou; Tanaka, Koji; Kurokawa, Yukinori; Yamamoto, Kazuyoshi; Saito, Takuro; Hagi, Takaomi; Momose, Kota; Yamashita, Kotaro; Makino, Tomoki; Kawai, Kunihiko; Serada, Satoshi; Fujimoto, Minoru; Hirota, Seiichi; Nakajima, Kiyokazu; Naka, Tetsuji; Eguchi, Hidetoshi; Doki, Yuichiro

Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.

一种新的生殖系 STAT3 功能获得性突变会导致自身免疫性疾病和严重的生长发育障碍。

Saito Koji, Fujimoto Minoru, Funajima Eiji, Serada Satoshi, Ohkawara Tomoharu, Ishihara Masayuki, Yamada Mamiko, Suzuki Hisato, Miya Fuyuki, Kosaki Kenjiro, Fujieda Mikiya, Naka Tetsuji

Lung CCR6(-)CXCR3(-) type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases

肺部 CCR6(-)CXCR3(-) 型 2 辅助性 T 细胞作为进行性纤维化间质性肺疾病的指标

Tsukuda, Tsukie Kin; Ohnishi, Hiroshi; Fujimoto, Minoru; Nakatani, Yu; Takamatsu, Kazufumi; Naka, Tetsuji; Yokoyama, Akihito

Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

更正:脂肪分解刺激的脂蛋白受体过度表达是胃癌预后不良的新型预测因子,也是潜在的治疗靶点。

Sugase, Takahito; Takahashi, Tsuyoshi; Serada, Satoshi; Fujimoto, Minoru; Ohkawara, Tomoharu; Hiramatsu, Kosuke; Koh, Masahiro; Saito, Yurina; Tanaka, Koji; Miyazaki, Yasuhiro; Makino, Tomoki; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Hanazaki, Kazuhiro; Mori, Masaki; Doki, Yuichiro; Naka, Tetsuji

Erratum: Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis

更正:富含亮氨酸的α-2糖蛋白是溃疡性结肠炎黏膜愈合的血清生物标志物

Shinzaki, Shinichiro; Matsuoka, Katsuyoshi; Iijima, Hideki; Mizuno, Shinta; Serada, Satoshi; Fujimoto, Minoru; Arai, Norimitsu; Koyama, Noriyuki; Morii, Eiichi; Watanabe, Mamoru; Hibi, Toshifumi; Kanai, Takanori; Takehara, Tetsuo; Naka, Tetsuji

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis

富含亮氨酸的α2糖蛋白是溃疡性结肠炎黏膜愈合的血清生物标志物

Shinzaki, Shinichiro; Matsuoka, Katsuyoshi; Iijima, Hideki; Mizuno, Shinta; Serada, Satoshi; Fujimoto, Minoru; Arai, Norimitsu; Koyama, Noriyuki; Morii, Eiichi; Watanabe, Mamoru; Hibi, Toshifumi; Kanai, Takanori; Takehara, Tetsuo; Naka, Tetsuji

Leucine-rich α-2 glycoprotein promotes lung fibrosis by modulating TGF-β signaling in fibroblasts

富含亮氨酸的α-2糖蛋白通过调节成纤维细胞中的TGF-β信号通路促进肺纤维化

Honda, Hiromi; Fujimoto, Minoru; Serada, Satoshi; Urushima, Hayato; Mishima, Takashi; Lee, Hyun; Ohkawara, Tomoharu; Kohno, Nobuoki; Hattori, Noboru; Yokoyama, Akihito; Naka, Tetsuji

Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma

以 Glypican-1 为靶点的抗体疗法在临床前研究中显示出对食管鳞状细胞癌的抗肿瘤活性

Harada, Emi; Serada, Satoshi; Fujimoto, Minoru; Takahashi, Yusuke; Takahashi, Tsuyoshi; Hara, Hisashi; Nakatsuka, Rie; Sugase, Takahito; Nishigaki, Takahiko; Saito, Yurina; Hiramatsu, Kosuke; Nojima, Satoshi; Mitsuo, Risa; Ohkawara, Tomoharu; Morii, Eiichi; Mori, Masaki; Doki, Yuichiro; Kaneda, Yasufumi; Naka, Tetsuji

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas.

卵巢和子宫内膜高级别浆液性癌具有相似的蛋白质表达谱

Hiramatsu Kosuke, Yoshino Kiyoshi, Serada Satoshi, Yoshihara Kosuke, Hori Yumiko, Fujimoto Minoru, Matsuzaki Shinya, Egawa-Takata Tomomi, Kobayashi Eiji, Ueda Yutaka, Morii Eiichi, Enomoto Takayuki, Naka Tetsuji, Kimura Tadashi